0001209191-18-031690.txt : 20180521
0001209191-18-031690.hdr.sgml : 20180521
20180521125413
ACCESSION NUMBER: 0001209191-18-031690
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180517
FILED AS OF DATE: 20180521
DATE AS OF CHANGE: 20180521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DORSA CAROLINE
CENTRAL INDEX KEY: 0001181174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 18848959
MAIL ADDRESS:
STREET 1: BIOGEN INC.
STREET 2: 225 BINNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-17
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001181174
DORSA CAROLINE
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
25.98
2018-05-17
4
A
0
19000
0.00
A
2028-05-16
Common Stock
19000
19000
D
This option was granted on May 17, 2018 with respect to 19,000 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
/s/ Jose Rivera, Attorney-in-Fact
2018-05-21